Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses

Paul J. Cozzi, Peter B. Burke, Amit Bhargav, Warren D.W. Heston, Bob Huryk, Peter T. Scardino, Yuman Fong

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses'. Together they form a unique fingerprint.

Medicine & Life Sciences